Goonasekera, Michelle. A.
Offer, Alison
Karsan, Waseem
El-Nayir, Muram
Mallorie, Amy E.
Parish, Sarah
Haynes, Richard J.
Mafham, Marion M. http://orcid.org/0000-0003-0562-3963
Funding for this research was provided by:
Medical Research Council (MC-UU_00017/3, MC-UU_00017/5)
British Heart Foundation
Cancer Research UK
Health Data Research UK
Article History
Received: 6 March 2023
Accepted: 1 February 2024
First Online: 1 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: S.P., M.M., A.O., R.H., M.G., WK, ME, and AEM work in the Clinical Trial Service Unit and Epidemiological Studies Unit of the Nuffield Department of Population Health at the University of Oxford. The Clinical Trial Service Unit and Epidemiological Studies Unit have a staff policy of not taking any personal payments directly or indirectly from industry (with reimbursement sought only for the costs of travel and accommodation to attend scientific meetings). It has received research grants from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, The Medicines Company, Merck, Mylan, Novartis, Novo Nordisk, Pfizer, Roche, Schering, and Solvay, which are governed by University of Oxford contracts that protect their independence.